ADAM17 and type 2 diabetes mellitus: Collectively, these findings, combined with previous studies, indicate that T2DM-induced SGC activation in the SG engages ADAM17 and amplifies cytokine shedding in the SG microenvironment, thereby sensitizing adjacent CPSNs, and the excitation of the latter could be involved in cardiac sympathetic overactivation in T2DM.